MedPath

Yonsei University

Yonsei University logo
🇰🇷South Korea
Ownership
Private
Established
1885-01-01
Employees
5K
Market Cap
-
Website
http://www.yonsei.ac.kr

Comparison of Desflurane and Propofol on Quality of Recovery in Patients Undergoing Robotic or Laparoscopic Gastrectomy

Not Applicable
Withdrawn
Conditions
General Anesthesia
Interventions
First Posted Date
2015-08-05
Last Posted Date
2019-02-15
Lead Sponsor
Yonsei University
Registration Number
NCT02515968

The Effect of Additional Propacetamol Infusion on Post Procedural Outcome and Opioid Consumption During Catheter Ablation of Atrial Fibrillation.

Not Applicable
Completed
Conditions
Arrhythmia
Interventions
Drug: Placebo
First Posted Date
2015-08-04
Last Posted Date
2019-01-28
Lead Sponsor
Yonsei University
Target Recruit Count
98
Registration Number
NCT02515188
Locations
🇰🇷

Department of Anaesthesiology and Pain Medicine, Yonsei University College of Medicine, Seoul, Korea, Republic of

A Randomized Controlled Comparison Between One Versus More Than Six Months of Dual Antiplatelet Therapy After Biolimus A9-eluting Stent Implantation

Not Applicable
Conditions
Coronary Artery Disease
Interventions
Device: BioFreedom with 1 month DAPT
Device: BioMatrix or Ultimaster with 6 to 12 months DAPT
First Posted Date
2015-08-03
Last Posted Date
2020-03-04
Lead Sponsor
Yonsei University
Target Recruit Count
3020
Registration Number
NCT02513810
Locations
🇰🇷

Division of Cardiology, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea, Republic of

Usefulness of Non-contrast MagnetIc Resonance imAging Versus Non-Contrast Ultrasonography for surveiLlancE of HepatoCellular Carcinoma [MIRACLE-HCC]

Not Applicable
Conditions
Compensated Liver Cirrhosis
Interventions
Radiation: Ultrasonography
Radiation: non-contrast MRI
First Posted Date
2015-08-03
Last Posted Date
2019-03-21
Lead Sponsor
Yonsei University
Target Recruit Count
416
Registration Number
NCT02514434
Locations
🇰🇷

Institute of Gastroenterology, Department of Internal Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea, Republic of

The Effects of Jerusalem Artichoke and Fermented Soybean Powder Mixture Supplementation on Glucose Control

Not Applicable
Completed
Conditions
Newly Diagnosed Type 2 Diabetes
Prediabetes
Interventions
Dietary Supplement: placebo
Dietary Supplement: jerusalem artichoke and fermented soybeans powder mixture
First Posted Date
2015-07-23
Last Posted Date
2015-07-23
Lead Sponsor
Yonsei University
Target Recruit Count
60
Registration Number
NCT02506582

Clinical Trial for Optimal Novel Oral Anticoagulant (NOAC) Schedule Immediate Before Catheter Ablation for Atrial Fibrillation

Not Applicable
Conditions
Atrial Fibrillation
Interventions
Drug: novel oral anticoagulant for 30 days
Drug: novel oral anticoagulant for 24 hour
First Posted Date
2015-07-21
Last Posted Date
2019-02-15
Lead Sponsor
Yonsei University
Target Recruit Count
433
Registration Number
NCT02504177
Locations
🇰🇷

Severance Cardiovascular Hospital, Yonsei University Health System, Seoul, Korea, Republic of

A Comparison of Propofol Based Total Intravenous Anesthesia and Desflurane Based Balanced Anesthesia on Hepatic Protection During Living-donor Liver Transplantation

Phase 4
Completed
Conditions
End Stage Liver Disease
Interventions
First Posted Date
2015-07-21
Last Posted Date
2017-07-05
Lead Sponsor
Yonsei University
Target Recruit Count
136
Registration Number
NCT02504138
Locations
🇰🇷

Department of Anesthesiology and Pain Medicine, Yonsei University College of Medicine, Seoul, Korea, Republic of

Effect of Midazolam Premedication on the Satisfaction Levels of Patients After Endoscopic Submucosal Dissection

Not Applicable
Completed
Conditions
Early Gastric Cancer
Gastric Adenoma
Interventions
First Posted Date
2015-07-21
Last Posted Date
2016-03-07
Lead Sponsor
Yonsei University
Target Recruit Count
72
Registration Number
NCT02504164
Locations
🇰🇷

Department of Anesthesiology and Pain Medicine, Anesthesia and Pain Research Institue, Yonsei Universiy College of Medicine, Seoul, Korea, Republic of

Regorafenib, C-kit Mutated Malignant Melanoma, 2nd Line Therapy

Phase 2
Conditions
Melanoma
Interventions
First Posted Date
2015-07-17
Last Posted Date
2021-04-05
Lead Sponsor
Yonsei University
Target Recruit Count
36
Registration Number
NCT02501551
Locations
🇰🇷

Severance Hospital, Yonsei University Health System, Seoul, Korea, Republic of

Afatinib, Paclitaxel, 2nd Line, Advanced Gastric Cancer

Phase 2
Completed
Conditions
Gastroesophageal Junction Cancer
Gastric Cancer
Interventions
First Posted Date
2015-07-17
Last Posted Date
2023-01-27
Lead Sponsor
Yonsei University
Target Recruit Count
72
Registration Number
NCT02501603
Locations
🇰🇷

Severance Hospital, Yonsei University Health System, Yonsei Cancer Center, Seoul, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath